Why Atrion Is Poised to Outperform

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, medical device maker Atrion (Nasdaq: ATRI  ) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Atrion and see what CAPS investors are saying about the stock right now.

Atrion facts

Headquarters (founded)

Allen, Texas (1944)

Market Cap

$395.8 million


Health care supplies

Trailing-12-Month Revenue

$116.1 million


CEO David Battat (since 2011)
CFO Jeffery Strickland (since 1997)

Return on Equity (average, past 3 years)


Cash / Debt

$38.7 million / $0

Dividend Yield



Baxter International (NYSE: BAX  )
Covidien (NYSE: COV  )
Teleflex (NYSE: TFX  )

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 97% of the 257 members who have rated Atrion believe the stock will outperform the S&P 500 going forward.

Just last month, one of those bulls, fellow Fool Buck Hartzell (TMFBuck), succinctly summed up the outperform case for our community: "Great capital allocators here. Look at their returns on equity. Surprisingly diversified for a small cap company. I like the ownership and the capital allocation decisions. This is a long term hold."

If you want market-thumping returns, you need to put together the best portfolio you can. Of course, despite a strong four-star rating, Atrion may not be your top choice.

We've found another growth play we are incredibly excited about -- excited enough to dub it "The Only Stock You Need to Profit from the NEW Technology Revolution." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2140350, ~/Articles/ArticleHandler.aspx, 10/24/2016 2:33:52 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,219.30 73.59 0.41%
S&P 500 2,150.38 9.22 0.43%
NASD 5,303.35 45.94 0.87%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 12:43 PM
ATRI $432.36 Up +5.37 +1.26%
Atrion CAPS Rating: ***
BAX $48.38 Up +0.20 +0.41%
Baxter CAPS Rating: ****
COV.DL $0.00 Down +0.00 +0.00%
Covidien CAPS Rating: *****
TFX $167.45 Down -0.35 -0.21%
Teleflex CAPS Rating: **